603108.SS · 润达医疗
China A-shares · RS rating 50 · As of 2026-10-14
| Price | 9.87 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 78 / 76 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 21 / 15 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +11.4% |
| Distance from 52-week high | +50.8% |
| Market cap (USD) | $873.4M |